Device for the implantation and fixation of prosthetic valves

Information

  • Patent Grant
  • RE45962
  • Patent Number
    RE45,962
  • Date Filed
    Thursday, August 7, 2014
    10 years ago
  • Date Issued
    Tuesday, April 5, 2016
    8 years ago
  • CPC
  • US Classifications
    • 001
    Field of Search
    • US
    • 623 001260
    • 623 002380
    • 623 002170
    • 623 002180
    • CPC
    • A61F2/24
    • A61F2/2418
    • A61F2/2427
    • A61F2/243
    • A61F2/2436
    • A61F2/2439
  • International Classifications
    • A61F2/24
Abstract
A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention relates to a device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent with a prosthetic heart valve at its proximal end.


2. Background Information


A device of this type is, in principle, known to medical technology. At present, biological or mechanical valve models are available to substitute for human heart valves which are usually fixedly sewn into the bed of the heart valve during a surgical procedure through an opening in the chest after removal of the diseased heart valve. In this surgical procedure, the patient's circulation must be maintained by a heart-lung machine, whereby cardiac arrest is induced during the implantation of the prosthetic heart valve. This consequently makes the surgical procedure a risky one coupled with the associated risks for the patients and a lengthy post-operative treatment phase. In particular, such a procedure cannot be performed on patients whose hearts are already too weak.


Minimally-invasive treatment procedures of recent development are characterized in particular by requiring a considerably shortened duration of anesthesia. One approach provides for implanting a self-expanding prosthetic heart valve with an artificial heart valve and a collapsible and expandable stent connected to the heart valve into the human body by means of an appropriate catheter system. The catheter system is used to guide such a self-expanding prosthetic heart valve through a femoral artery or vein to its site of implantation at the heart. After reaching the site of implantation, the stent, which consists for example of a plurality of self-expanding stent segments which can be bent relative one another in the longitudinal direction, can then be successively expanded. Following the expansion, anchoring hooks can for example support the anchoring of the prosthetic heart valve at least in the respective blood vessel close to the heart. The actual prosthetic heart valve itself is thereby in the direct proximal area of the stent.


Known for example from the DE 100 10 074 A1 printed publication is a device for fastening and anchoring prosthetic heart valves, which is essentially formed from wire-shaped interconnected elements. The device provides for using various different arched elements in order to attain a secure retention and support for the prosthetic heart valve. To this end, the device described in this printed publication makes use of three identical pairs of arched elements, offset from one another by 120°. These arched elements are interconnected by means of solid articulations, whereby the solid articulations fulfill the function of pivot bearings. Additional arched elements bent opposite to each other are furthermore provided which form rocker arms as equal in length as possible in order to achieve a secure anchoring of the arched elements even when subject to peristaltic actions on the heart and blood vessels and a solid sealing for an implanted and anchored prosthetic heart valve.


In the known solutions, however, there is a risk of heart valve implant malalignment. This essentially refers to the exact positioning and angular adjustment of the prosthetic heart valve to be implanted. In particular, it is only with immense skill on the part of the person performing the implantation—if at all—that a stent with the prosthetic heart valve at its proximal end winds up being positioned so precisely in the proximity of the patient's diseased heart valve that both sufficient lateral positioning accuracy as well as a suitable angular position to the prosthetic heart valve can be optimally ensured. The known solutions are also only conditionally suitable for explanting improperly or incorrectly positioned prosthetic heart valves. Such a process is usually only possible with great effort; in particular, a further surgical procedure is required.


Among other complications, an implantation malalignment of a less than optimally positioned prosthetic heart valve can lead to, for example, leakage or valvular regurgitation, which puts a substantial burden on the ventricle. Should, for example, a prosthetic heart valve be implanted too high above the actual heart valve plane, this can lead to occlusion of the coronary artery origination (coronaries) and thus to a fatal coronary ischemia with myocardiac infarction. It is therefore imperative for an implanted prosthetic heart valve to meet all the respective requirements for both the accuracy of the lateral positioning as well as the angular positioning.


In conventional implantation techniques in which self-expanding prosthetic heart valves are, for example, guided through a patient's femoral artery to the site of deployment at the heart in a minimally-invasive procedure, the prosthesis is usually introduced using a guide wire and catheters, whereby conventional balloon catheters can also be used. Although such a surgical introduction can be monitored and controlled, for example with fluoroscopy (Cardiac Catheterization Laboratory=CCL) or with ultrasound (Trans-esophageal Echocardiogram=TEE), oftentimes—due to the limited maneuverability of the prosthetic heart valve which is still in a collapsed state during the introduction procedure and despite being in the collapsed state is still of relatively large size—it is not possible to ensure the required positioning accuracy and especially the angular position to the prosthetic heart valve implant with the corresponding anchoring elements affixed thereto. In particular—as a result of a possible coronary artery occlusion—an anglular misalignment to the implanted prosthetic heart valve from the optimum site of deployment can pose a threat to the respective patient.


In designing a prosthetic heart valve, special consideration must, in particular, be given to the substantial forces also acting on the prosthesis during the filling period of the cardiac cycle (diastole), necessitating a secure anchorage in order to prevent the implanted prosthetic heart valve from dislodging.


Hence on the one hand, the prosthetic heart valve must be able to be maneuvered as much as possible in the respective coronary artery during the implantation procedure so as to ensure optimum positioning accuracy and, on the other hand, the implanted prosthesis must be able to be firmly anchored at its site of implantation in order to effectively prevent subsequent prosthesis misalignment.


The present invention addresses the problem that the known devices for transvascular implantation and fixation of prosthetic heart valves are often not suitable for easily implanting a prosthetic heart valve in a patient's ventricle with the necessary positioning accuracy. In particular, the necessary lateral positioning accuracy and the angular position of the prosthetic heart valve can usually only be sufficiently guaranteed when the person performing the procedure has the corresponding experience. On the other hand, explanting a previously implanted prosthetic heart valve in a minimally-invasive procedure or accordingly correcting an incorrectly positioned prosthetic heart valve has to date only been possible with great effort, if at all.


On the basis of this problem as set forth, the present invention proposes a device which enables a prosthetic heart valve to be implanted into a patient in a minimally-invasive procedure in as simple a manner as possible, wherein an increased positioning accuracy to the prosthesis in the patient's ventricle can in particular be ensured. Such a device is to, in particular, reduce the risk of an incorrect deployment to the greatest extent possible.


SUMMARY OF THE INVENTION

According to the invention, this task is solved by a device as described at the outset by the device having, in addition to the self-expanding heart valve stent with a prosthetic heart valve at its proximal end, a self-expanding positioning stent insertable into a position in the patient's aortic valve, which is configured separate from the heart valve stent, wherein the positioning stent and the heart valve stent are configured such that they each work in concert in their expanded states so that the positioning stent helps to hold the heart valve stent in a position relative the patient's heart valve predefined by the positioning stent.


The device according to the invention exhibits an entire array of substantial advantages over the prosthetic heart valves known from the prior art and described above. The two-part configuration of the device in the design of the heart valve stent and the positioning stent configured separately therefrom can, in particular, greatly increase the positioning accuracy of the prosthetic heart valve in the patient's ventricle. The positioning stent hereby primarily assumes the function of determining the position of the prosthetic heart valve in the patient's ventricle as well as the function of anchoring or fixing the prosthesis at optimum placement. In particular, the prosthetic heart valve is not on or in the positioning stent, but instead configured separately from the positioning stent on the heart valve stent. This has the advantage that the dimensions of the positioning stent in its collapsed state are extremely small, which increases the stent's maneuverability.


The heart valve stent primarily serves the inventive device only as a supporting structure for the prosthetic heart valve to be implanted. This function sharing enables both the positioning stent as well as the heart valve stent to be of relatively simple configuration. What can be achieved in particular is that compared to a stent on which both a prosthetic heart valve as well as means for positioning and fixing the prosthetic heart valve are arranged, the positioning stent can be configured to exhibit only relatively small dimensions in its collapsed state. Inserting the positioning stent in the patient's artery is thus—due to the better maneuverability achieved—substantially simpler. A direct consequence of this is increased positioning accuracy for the positioning stent.


The device according to the invention is configured in such a manner that not until the positioning stent is positioned into the patient's artery and after aligning the stent with respect to a predefinable axial rotation and horizontal position relative an (old) heart valve of the patient is the heart valve stent configured separately from the positioning stent inserted into the artery or vein. During the insertion procedure, the heart valve stent, which has the prosthetic heart valve at its proximal end, independently orientates itself to the exactly-positioned positioning stent as fixed at the arterial wall. Specifically, the heart valve stent is independently guided within the expanded positioning stent into the implantation position predefined by the positioning stent at which the prosthetic heart valve is in an optimum position relative the patient's old heart valve. After the heart valve stent, aided by the positioning stent, has positioned into the coronary artery in the predefined position relative the old heart valve, the full expansion of the heart valve stent is induced, for example by an external manipulation, as a consequence of which the heart valve stent according to the invention interacts with the positioning stent in such a way that the heart valve stent, and thus also the prosthetic heart valve disposed at its proximal end, is positionally fixed into the implantation position. Accordingly, the positioning stent serves—in addition to the already mentioned function of defining the position for the prosthetic heart valve in the patient's ventricle and the function of anchoring or fixing the prosthesis at this position—also the function of guiding the heart valve stent into the optimum position for the prosthetic heart valve during the implantation procedure. The advantages attainable with the inventive device are obvious: in particular, an optimum positioning is enabled for the prosthetic heart valve in its final implanted position, whereby the alignment and fixing of the prosthetic heart valve ensues independently based on the co-operative action of the heart valve stent and the positioning stent. On the one hand, a position-contingent, inaccurate implantation of the prosthetic heart valve can hereby be excluded. On the other hand, the device is characterized by the implantation and anchoring of the prosthetic heart valve ensuing in a particularly simple manner.


Because the positioning stent according to the invention is configured to be an insertable, self-expanding component in a patient's blood vessel, it can be inserted beforehand; i.e., prior to the actual implantation of the prosthetic heart valve disposed at the proximal end of the heart valve stent. It would thus be conceivable here for the positioning stent to first be brought into the aorta and optimally positioned and fixed there, whereby the heart valve stent with the prosthetic heart valve is thereafter introduced and inserted optimally by means of the positioning stent already in position and fixed there.


According to the invention, both the heart valve stent as well as the positioning stent are configured to self-expand, which facilitates the respective introduction of these components. Because the positioning stent assuming the task of determining the position for the heart valve stent, the prosthetic heart valve disposed thereon respectively, can be configured to be substantially smaller in comparison to previous self-expanding prosthetic heart valves, the maneuverability of the positioning stent is increased considerably, which ultimately results in being able to select an extremely precise position at which the positioning stent is anchored relative the heart valve and one ideally adapted to the respective requirements. This advantage of exact positioning of the easily-maneuvered and minutely-configured positioning stent extends to the subsequent implantation of the prosthetic heart valve since the heart valve stent, at the proximal end of which the prosthetic heart valve is arranged, is held in the position defined by the (optimally positioned) positioning stent.


Advantageous further developments of the inventive device are specified in the dependent claims.


One particularly advantageous development with respect to insertion of the heart valve stent provides for the heart valve stent to be configured to be reversibly expandable and collapsible. It is thereby conceivable for the heart valve stent to be collapsed, for example via external manipulation, and extracted using an explantation catheter. Specifically, this embodiment enables the heart valve stent in collapsed form to be connectably received in a cartridge of a positioning catheter, an explantation catheter respectively. In order for the heart valve stent to be optimally inserted into a patient's blood vessel and positioned there in a predefined position relative the heart valve, it is necessary for the positioning stent to be as small as possible in its collapsed state so that the stent can be optimally navigated with as little impact as possible on the heart valve. This is achieved by the prosthetic heart valve implant not being affixed to the positioning stent but rather to the heart valve stent. The positioning stent is furthermore configured such that all the components of the stent in the collapsed state have a certain measure of pretensioning acting in a radially outward direction which effects the self-expansion following release from the cartridge. The positioning stent can then be implanted with the cartridge in conventional manner using a positioning stent catheter, for example through a femoral artery. Should the positioning stent be inaccurately deployed, for example if the positioning stent is not positioned precisely accurately in the patient's aorta, or when an explantation of the positioning stent is necessary for other reasons, it is provided for the positioning stent to be convertible from its expanded state back into its collapsed state. This is done for example by external manipulation using an implantation catheter. The positioning stent is thus fully reversibly withdrawable in the catheter, which enables the stent to be completely removed.


The inventive device for transvascular implantation and fixation of prosthetic heart valves can advantageously provide for the positioning stent to have an anchorage at its proximal end, in particular an anchoring support, whereby this anchoring support is configured such that the positioning stent self-positions into a pre-defined position relative the patient's heart valve in its expanded state and is held by means of the anchoring support. The positioning stent is thereby configured such that the anchoring support is received in collapsed form in a cartridge connectable with a catheter. The anchoring support is thereby to be compressed such that it is pretensioned in a radially outward direction which effects the self-expansion following release from the cartridge. Configuring the positioning stent so that it self-positions into a given position relative the patient's heart valve in its expanded state and is held there by means of the anchoring support enables the position of the positioning stent and thus the position of the heart valve stent to be precisely definable beforehand so that inaccurate implantations, as can occur with the known solutions, can be excluded.


In order to facilitate the positioning stent's self-expansion, the positioning stent'can advantageously furthermore exhibit pretensioning elements in order to radially pretension the positioning stent in its position defined by the anchorage. The pretensioning elements are thereby also configured to be reversible so that their pretensioning function can be countermanded by external manipulation, which enables the positioning stent to be collapsed and thus be retracted into a catheter, enabling the positioning stent to be removed completely.


An advantageous realization of the latter embodiment provides for the anchoring support to have at least one support strut which is configured such that it self-positions into the pockets of the patient's heart valve in the expanded state of the positioning stent and thus fixes the orientation of the positioning stent relative the heart valve in the axial and horizontal direction. Hereby conceivable would be, for example, that the support struts configured at the proximal end of the positioning stent implant independently in the pockets of the respective patient's heart valve during the implantation procedure, whereby the pockets of the heart valve form a counter bearing for counteracting the proximal insertion motion so that the anchoring supports can be precisely positioned laterally with the positioning stent. Since the pockets represent a guide per se for the support struts during insertion, this ensures at the same time that the anchoring support and the positioning stent can adopt a precise angular position. Only after the support struts have been introduced into the pockets of the respective patient's heart valve and the final position for the positioning stent has been reached is the heart valve stent configured separately from the positioning stent deployed with the help of, for example, a heart valve catheter. The heart valve stent exhibiting the prosthetic heart valve at its proximal end is then optimally implanted at the most favorable and ideal site by means of the positioning stent already having been exactly positioned and fixed. To be mentioned as a further advantage is that the support struts of the positioning stent are positioned at the patient's heart valve following implantation of the positioning stent. Because the positioning stent is of relatively simple configuration, since it for example does not comprise the prosthetic heart valve which is disposed separately from the positioning stent on the heart valve stent, the struts of the positioning stent can exhibit a relatively large radius, which entails a lesser risk of injury to the heart valve.


The support strut disposed on an anchoring support or anchorage should be curved convexly and arcuately in the proximal direction because such a rounded form wards off injuries to the heart's blood vessel as well as facilitates the unfolding in the self-expansion process. With such a design, inserting the support struts into the pockets of the old heart valve is thus likewise easier without engendering any corresponding injuries to the tissue or the blood vessels of the region.


Additional stabilizing struts can also be provided on the anchoring supports, which achieves increased fixedness following the self-expansion of the anchored anchoring supports. Such stabilizing struts can be advantageous since in order to benefit from the self-expansion effect required of an anchoring support for securely fixing the anchoring support with the positioning stent, accepting that the anchoring supports collapsed within a to cartridge during the introduction phase must be of the smallest volume possible, small cross-sections for the respective struts must be maintained.


All the struts of an anchoring support should thereby be arranged, configured and dimensioned such that the successively ensuing release of the supporting struts and the other struts with the further elements provided on an anchoring support, as the case may be, can be achieved by the appropriate manipulation of cartridge and/or catheter. In so doing, the design of the cartridge or at least a portion of the cartridge should, of course, also be taken into consideration.


Corresponding to physical anatomy, three supporting struts each arranged at the same angular spacing from one another on the anchoring support should be provided. Yet there is also the possibility of arranging each of the supporting struts disposed on an anchoring support to be at an angular offset from one another. In this case, the supporting struts with their proximal members are then introduced into the pockets of an old heart valve in the implanted state and the old heart valve can then be tightly secured and fixed with the supporting struts.


The stability of an implanted and fixed positioning stent can be optimally increased by means of at least one ring support, which can be an element on an anchoring support. Thus, by means of such a ring support, the possibility exists of connecting different struts provided on an anchoring support, preferably at their bases. It is thereby not imperative to provide a connection between the ring support and all the struts of an anchoring support.


After the positioning stent is positioned at the heart and held there by the anchorage, the heart valve stent is introduced. It is hereby advantageously provided for the heart valve stent to be configured such that the prosthetic heart valve in its expanded state presses the patient's heart valve against the aorta wall, whereby the at least one anchorage of the positioning stent positions between the aorta wall and the heart valve expanded by the prosthetic heart valve.


In order to have the heart valve stent be held in a position defined by the positioning stent relative the patient's heart valve using the positioning stent, the positioning stent has at least one engaging element at its distal end. The heart valve stent should thereby exhibit a correspondingly complementary-configured retaining element at its distal end, whereby in the expanded state of the positioning stent and in the fully expanded state of the heart valve stent, the at least one retaining element forms a positive connection with the at least one engaging element of the positioning stent. This thus achieves the positioning of the prosthetic heart valve in the coronary artery in the position predefined by the positioning stent and it being held there by the positioning stent. It would hereby be conceivable to provide engaging clips on the heart valve stent. The engaging clips are thereby among the elements of the heart valve stent which are not released to expand until the heart valve stem is accurately inserted into its implantation deployment site at the patient's heart valve by means of the already implanted positioning stent. When the engaging clips of the heart valve stent expand, they engage with the engaging elements of the positioning stent and thus hold the heart valve stent in the position given by the positioning stent. At the same time, portions of the respective patient's old heart valve then each work into an anchoring strut of the positioning stent and the expanded prosthetic heart valve so that the respective portions of the old heart valve can be clamped and held between these elements following the successful expanding of the prosthetic heart valve, similar to how a sheet of paper is held between the brackets of a paper clip.


The heart valve stent is in particular configured such that it does not adopt its fully expanded state, in which both the prosthetic heart valve as well as also the retaining element is released, until the heart valve stent is in the position as defined by the positioning stent.


As is the case with the positioning stent, the heart valve stent is also advantageously configured to be reversible in its folding action, whereby the positive connection with the positioning stent is disengaged in the collapsed state. This thus allows the prosthetic heart valve disposed on the heart valve stent to again be explanted, for example in the case of an improper implantation, without also having to extract the positioning stent in order to do so.


In order to facilitate explantation of the heart valve stent, explantation elements can be provided at the distal end of the heart valve stent which work in concert with the heart valve stent such that when externally manipulated, for example, the explantation elements disengage the positive connection between the heart valve stent and the positioning stent, and the heart valve stent collapses. One advantageous realization of the explantation elements provides for their being engageable, for example by means of an explantation catheter, whereby retracting the explantation elements in the explantation catheter disengages the positive connection between the heart valve stent and the positioning stent, and the heart valve stent folds back up.


The heart valve stent is advantageously accommodated in the collapsed state in a cartridge connectable to a heart valve stent catheter and/or explantation catheter, whereby a predefinable motion of the cartridge will release the heart valve stent. Specifically, it is thereby advantageously provided that a predefinable first motion of the cartridge will only release the prosthetic heart valve to expand, whereby the retaining element of the heart valve stent is released by at least one second subsequent motion of the cartridge, the catheter respectively.


It can be advantageous, in particular for the subsequent cartridge and catheter movement, which leads to the sequential release of the individual elements of the heart valve stent, to use a multi-part cartridge, whereby at least two individual parts can each be moved relative one another. Hence, the movements of a cartridge or individual parts of a cartridge to be realized, for example so as to lead to self-expansion, can be a proximal and/or distal displacement, which can ensue in several successive stages, each covering different paths in order to successively release the corresponding parts for their respective expansion during implantation.


Thus, a first movement, for example, can be a distal retraction of the cartridge or a portion of a cartridge. Should it hereby be necessary so as to avoid inaccurate implantation, a proximal movement of the cartridge or a portion of a cartridge can then be effected to re-collapse the already-expanded retaining elements acting radially outwardly with a pretensioning force, the prosthetic heart valve of the heart valve stent respectively, and to bring same into the interior of the cartridge so as to enable the device to be removed from the patient. Bowden cables or flexible push tubes guided through the interior of the catheter to the cartridge or to a portion of the cartridge can be used as the actuating elements for a manipulation and the associated displacing movement of the cartridge or individual parts of the cartridge. Such actuating elements can, however, also engage with fastening elements, for example eyelets, provided on the anchoring support.


The solution according to the invention thus also provides the possibility of aborting prosthetic heart valve implantations which will be unsuccessful and removing the device again by withdrawing the catheter, whereby in so doing, the heart valve stent which has already expanded re-collapses again and can be guided back into a cartridge or a portion of a cartridge.


An advantageous further development of the device according to the invention provides for the positioning stent to furthermore comprise anchoring elements, in particular hooks, in order to anchor the positioning stent in its predefinable position at the heart. Additionally or alternatively to the positioning stent, it would be conceivable for the heart valve stent to also comprise anchoring elements such as hooks, for example, in order to anchor the heart valve stent in the position in the aorta as predefined by the positioning stent. Both solutions ultimately serve the secure fixing of the implanted prosthetic heart valve at its site of implantation as predefined by the positioning stent.


In order to facilitate spatial orientation when inserting the positioning stent, markers can be disposed on the positioning stent, in particular x-ray markers. Of course, other solutions are also conceivable. For example, insertion of the positioning stent can also be monitored and controlled using fluoroscopy (Cardiac Catheterization Laboratory=CCL) or ultrasound (Transesophageal Echocardiogram=TEE).


The positioning stent and/or the heart valve stent can furthermore exhibit guiding means which are configured in such a manner that the heart valve stent is guided independently in the expanded positioning stent into the position predefined by the positioning stent. It would hereby be conceivable for the guiding means to be configured as elements tapering to the distal end of the positioning stent, the heart valve stent respectively, so as to realize a self-adjusting of the heart valve stent in the positioning stent and thus into the position predefined by the positioning stent.


The device according to the invention can also be used together with a balloon catheter. With a balloon catheter, the old heart valve can be pushed away prior to the self-expansion of the anchoring support.


The following will make reference to the figures in describing preferred embodiments of the device according to the invention for the implantation and fixation of prosthetic heart valves in greater detail.





BRIEF DESCRIPTION OF THE DRAWINGS

In the drawings:



FIG. 1: a preferred embodiment of a positioning stent of the device according to the invention in the inserted and expanded state;



FIG. 2A: a preferred embodiment of a heart valve stent of the device according to the invention in the expanded state;



FIG. 2B: the heart valve stent of FIG. 2A in the implanted state;



FIG. 3A,B: one schematic representation each to illustrate the explantation process with a preferred embodiment of the heart valve stent, and



FIG. 4: a detailed representation of the explantation elements provided on the heart valve stent, the positioning stent respectively, as well as their mode of operation.





DETAILED DESCRIPTION OF AN ILLUSTRATIVE EMBODIMENT


FIG. 1 shows a preferred embodiment of a positioning stent 20 for the device according to the invention in the inserted state. The positioning stent 20 is in its expanded state in the embodiment shown. As depicted, the positioning stent 20 has an anchoring segment 21′ with anchoring supports 21 at its proximal end. The anchoring supports 21 are hereby configured such that they optimize themselves into the pockets T of the old heart valve relative to axial rotation as well as horizontal position. To this end, the positioning stent 20 is supported by means of anchoring supports 21 in pockets T of the old heart valve. The anchoring supports 21 themselves are connected to docking segment 23 by means of shoulders 22. The docking segment 24′ of positioning stent 20, provided at its distal end, exhibits a plurality of engaging elements 24 which fix a heart valve stent to be implanted (not explicitly shown in FIG. 1).


The positioning stent 20 is configured as a self-expanding component. Due to the simple configuration of positioning stent 20, which essentially consists only of anchoring segment 21′, docking segment 24′ and shoulders 22, the positioning stent 20 exhibits extremely small dimensions when in its collapsed state. Thus, when inserting positioning stent 20, for example using a positioning stent catheter, the positioning stent 20 has very good maneuverability within aorta A. After positioning stent 20 has been inserted into aorta A, it is expanded, enabled, for example, by means of an external manipulation of the positioning stent catheter. The anchoring supports 21 of the expanded positioning stent 20 self-position into the pockets T of the patient's heart valve, whereby the alignment of the positioning stent 20 in the axial and horizontal direction is fixed relative the heart valve. So that the positioning stent 20 will expand independently, suitable pretensioning elements can be (optionally) provided. In the embodiment as shown, pretensioning elements are realized in the form of anchoring supports 21.


After positioning stent 20 is inserted into aorta A and positioned and fixed there as described above, a heart valve stent 10 (FIG. 2A) disposed with a prosthetic heart valve 11 at its proximal end is inserted into positioning stent 20. It expands subsequent to release and, in doing so, presses the old valve against the aorta wall, the positioning stent 20 respectively.



FIG. 2A shows a heart valve stent 10 in the expanded state. As depicted, the heart valve stent 10 has the prosthetic heart valve 11 at its proximal end and an anchoring segment 12′ comprising at least one retaining element 12 at its distal end.



FIG. 2B provides a representation of how the heart valve stent 10 is held in the already positioned and fixed positioning stent 20. The heart valve stent 10 is guided by guide elements 17, 27 in positioning stent 20 relative to rotation and axial position such that the new heart valve is optimally positioned. Thereafter, further releasing of the heart valve stent 10 introduces its anchoring segment 12′ into docking segment 24′ (FIG. 1) of the positioning stent 20. The anchoring segment 12′ comprises retaining elements 12 which form a positive connection with the engaging elements 24 of the positioning stent 10 in order to position the prosthetic heart valve 11 in the position in the coronary artery as predefined by the positioning stent 20 and to hold same there by means of positioning stent 20.


Unlike conventional heart valve stents, the heart valve stent 10 of the present device does not have retaining clips to engage behind the old heart valve but rather engaging clips in the form of retaining elements 12 in the anchoring segment 12′ of heart valve stent 10. These engaging clips interact with the engaging elements 24 disposed in the docking segment 24′ of positioning stent 20. The advantage of this is that the heart valve stent 10 is commutably anchored in positioning stent 20. By means of its self-expanding induced by guide means 17, 27, heart valve stent 10 independently slides inside positioning stent 20 and cannot slide any further. The guide means 17, 27 are configured as elements tapering to the distal end of positioning stent 20 and/or heart valve stent 10. Due to the special design of engaging elements 23 of positioning stent 20 and the retaining elements 12 of heart valve stent 10 as clips formed in zigzag fashion (Z-clips), a finer angular positioning of the heart valve stent 10 can in particular ensue. Both the positioning stent 20 as well as the heart valve stent 10 can be configured of individual segments, whereby the individual segments can be rotated relative one another. This increases flexibility when inserting the two stents into the aorta. It is in particular possible to realize a finer angular positioning to heart valve stent 10. It is thus conceivable, for example, for the physician to alternatively insert a rotated prosthetic heart valve 11. The segmented configuration is also of advantage with respect to the collapsing of the heart valve stent and the positioning stent since the segmented stents in collapsed state can be housed compressed within a catheter.



FIGS. 3A, 3B and 4 are schematic representations of how the heart valve stent 10 in the already positioned and implanted positioning stent 20 can be explanted. In the event of a valve dysfunction, the mechanically stable connection between the positioning stent 20 and the heart valve stent 10 as described above can be disengaged again by external manipulation. This can be realized, for example, by using a catheter 30 with a cartridge 33 affixed thereto to engage explantation elements 13. After retracting the explantation elements 13 into the variable funnel-shaped explantation catheter 30, the heart valve stent 10 is pulled into same and can thus be replaced with a new one. The positioning stent 20 remains as a marking and anchoring base for a new heart valve stent 10. Positioning stent 20 can, of course, also be explanted in a similar procedure.


The docking segment 24′ of the positioning stent can comprise eyelets or nubs to which the explantation catheter 30 is to be affixed in order to effect such an explantation. Attaching to eyelets is possible via preferably three to six eyelets and three to six loops which are subsequently pulled out of the eyelets. The positioning stent 20 as well as the heart valve stent 10 is in particular completely reversibly withdrawable in the catheter, which enables the complete removal of the positioning stent and/or the heart valve stent.


The disengaging of the mechanically stable connection between positioning stent 20 and heart valve stent 10 by means of external manipulation, in the case of valve dysfunction for example, is possible when the previously implanted heart valve stent 10 exhibits a retrievable structure suitable for this purpose. This could consist of a plurality of connecting struts which project medially from the upper outer end of the stent into the vascular lumen and join there with an anchoring device (eyelet, hook, nub, etc.). Should this anchoring device now be grasped by the retrieval catheter wire of catheter 30, the distal portion of heart valve stent 10 can thus be compressed toward the lumen and drawn into a catheter tube 33. This then again provides the opportunity of using the positioning stent 20 which remains as a marking and anchoring base for a new heart valve stent 10.


The positioning stent 20 is made from a solid mesh (wire, polymer, etc.) or produced in a laser-cutting process. Applicable as suitable materials for the positioning stent are NiTi, high-grade steel or biocompatible plastics. For spatial orientation, x-ray markers can furthermore be disposed on positioning stent 20.

Claims
  • 1. A valve prosthesis, comprising: a first stent component including (i) a first portion disposed at a proximal end of the first stent component that is positionable radially outward from at least a portion of a native leaflet of a native heart valve and radially inward of a vessel wall adjacent the native heart valve when the first stent component is implanted relative to the native heart valve, the first portion including exactly three support struts, and (ii) a second portion disposed at a distal end of the first stent component, opposite the proximal end, wherein the distal end of the first stent component is positioned farther away from a native heart than the proximal end of the first stent component when the first stent component is implanted relative to the native heart valve;a second stent component including (i) a first portion disposed at a proximal end of the second stent component that is positionable radially inward of at least a portion of the native leaflet adjacent the first portion of the first stent component when the second stent component is implanted relative to the native heart valve, and (ii) a second portion disposed at a distal end of the second stent component, opposite the proximal end, wherein the distal end of the second stent component is positioned farther away from the native heart than the proximal end of the second stent component when the second stent component is implanted relative to the native heart valve; anda prosthetic valve component attached to the second stent component.
  • 2. The valve prosthesis of claim 1, wherein: the first stent component further includes an annular attachment element disposed at the distal end of the first stent component;the second stent component further includes an annular attachment element disposed at the distal end of the second stent component; andthe annular attachment element of the first stent component engages the annular attachment element of the second stent component when the first and second stent components are implanted relative to the native heart valve.
  • 3. The valve prosthesis of claim 2, wherein the second stent component further includes at least one strut extending in a distal direction away from the annular attachment element of the second stent component.
  • 4. The valve prosthesis of claim 3, wherein the second stent component further includes at least one eyelet disposed at a distal end of the at least one strut and configured to be grasped by a retrieval catheter.
  • 5. The valve prosthesis of claim 1, wherein the prosthetic valve component is attached to the second stent component at the proximal end of the second stent component.
  • 6. The valve prosthesis of claim 1, wherein the first stent component is self expanding and includes a collapsed mode when the first stent component is being delivered to an implantation site adjacent the native valve and an expanded mode when the first stent component is implanted relative to the native heart valve.
  • 7. The valve prosthesis of claim 1, wherein the second stent component is self-expanding and includes a collapsed mode when the second stent component is being delivered to an implantation site adjacent the native heart valve and an expanded mode when the second stent component is implanted relative to the native heart valve.
  • 8. The valve prosthesis of claim 1, wherein the first stent component includes at least oneeach support strut disposed at the proximal endof the exactly three support struts of the first stent component that is positionable within a respective pocket of the native heart valve when the first stent component is implanted relative to the native heart valve.
  • 9. The valve prosthesis of claim 8, wherein the at least oneeach support strut of the exactly three support struts of the first stent component is curved convexly in a proximal direction of the first stent component.
  • 10. The valve prosthesis of claim 1, wherein the first stent component includes three support struts disposed at the proximal end of the first stent component, each support strut of the exactly three support struts of the first stent component is respectively positionable within one of three pockets of the native heart valve, the native heart valve being an aortic valve, when the first stent component is implanted relative to the native heart valve.
  • 11. The valve prosthesis of claim 10, wherein the exactly three support struts are substantially equally spaced from one another.
  • 12. The valve prosthesis of claim 1, wherein the second stent component has sufficient radial strength to press the native heart valve against a wall containing the native heart valve.
  • 13. The valve prosthesis of claim 1, wherein at least one of the first stent component and second stent component is self-expanding.
  • 14. The valve prosthesis of claim 13, wherein both of the first stent component and second stent component are self-expanding.
  • 15. The valve prosthesis of claim 1, wherein at least one of the first stent component and second stent component is convertible from an expanded state to a collapsed state.
  • 16. The valve prosthesis of claim 1, wherein both of the first stent component and second stent component are convertible from an expanded state to a collapsed state.
  • 17. The valve prosthesis of claim 1, wherein the first stent component and second stent component are rotatable relative to each other for positioning relative to the native heart valve.
  • 18. A valve prosthesis, comprising: a first stent component including (i) a first portion disposed at a proximal end of the first stent component that is positionable radially outward from at least a portion of a native leaflet of a native heart valve and radially inward of a vessel wall adjacent the native heart valve when the first stent component is implanted relative to the native heart valve, the first portion including exactly three support struts, and (ii) a second portion disposed at a distal end of the first stent component, opposite the proximal end, wherein the distal end of the first stent component is positioned farther away from a native heart than the proximal end of the first stent component when the first stent component is implanted relative to the native valve;a second stent component including (i) a first portion disposed at a proximal end of the second stent component that is positioned radially inward of at least a portion of the native leaflet adjacent the first portion of the first stent component when the stent is implanted relative to the native heart valve, and (ii) a second portion disposed at a distal end of the second stent component, opposite the proximal end, wherein the distal end of the second stent component is positioned farther away from the native heart than the proximal end of the second stent component when the second stem component is implanted relative to the native heart valve; and a prosthetic valve component attached to the second stent component at the proximal end of the second stent component;wherein the first portion of the first stent component and the first portion of the second stent component are configured to clamp at least a portion of the native leaflet.
  • 19. The valve prosthesis of claim 18, wherein: the first stem component further includes an annular attachment element disposed at the distal end of the first stent component;the second stent component further includes an annular attachment element disposed at the distal end of the second stent component; andthe annular attachment element of the first stent component engages the annular attachment element of the second stent component when the first and second stent components are implanted relative to the native heart valve.
  • 20. The valve prosthesis of claim 19, wherein the second stent component further includes at least one strut extending in the distal direction away from the annular attachment element of the second stent component.
  • 21. The valve prosthesis of claim 20, wherein the second stent component further includes at least one eyelet disposed at a distal end of the at least one strut and configured to be grasped by a retrieval catheter.
  • 22. The valve prosthesis of claim 18, wherein the first stent component is self-expanding and includes a collapsed mode when the first stent component is being delivered to an implantation site adjacent the native heart valve and an expanded mode when the first stent component is implanted relative to the native heart valve.
  • 23. The valve prosthesis of claim 18, wherein the second stent component is self-expanding and includes a collapsed mode when the second stent component is being delivered to an implantation site adjacent the native heart valve and an expanded mode when the second stent component is implanted relative to the native heart valve.
  • 24. The valve prosthesis of claim 18, wherein the first stent component includes at least oneeach support strut disposed at the proximal endof the exactly three support struts of the first stent component that is positionable within a respective pocket of the native heart valve when the first stent component is implanted relative to the native heart valve.
  • 25. The valve prosthesis of claim 24, wherein the at least oneeach support strut of the exactly three support struts of the first stent component is curved convexly in a proximal direction of the first stent component.
  • 26. The valve prosthesis of claim 18, wherein the first stent component includes three support struts disposed at the proximal end of the first stent component, each support strut of the exactly three support struts of the first stent component is respectively positionable within one of three pockets of the native heart valve, the native heart valve being an aortic valve, when the first stent component is implanted relative to the native heart valve.
  • 27. The valve prosthesis of claim 26, wherein the exactly three support struts are substantially equally spaced from one another.
  • 28. A valve prosthesis, comprising: a first stem component including (i) a first portion disposed at a proximal end of the first stent component that is positionable radially outward from at least a portion of a native leaflet of a native heart valve and radially inward of a vessel wall adjacent the native heart valve when the first stent component is implanted relative to the native heart valve, and (ii) a second portion disposed at a distal end of the first stent component, opposite the proximal end, wherein the distal end of the first stent component is positioned farther away from a native heart than the proximal end of the first stent component when the first stent component is implanted relative to the native heart valve;a single set of exactly three substantially equally spaced support struts disposed at the proximal end of the first stent component, each of the three support struts being curved convexly in a proximal direction of the first stent component and respectively positioned within one of three pockets of the native heart valve, the native heart valve being an aortic valve, when the first stent component is implanted relative to the native heart valve;a second stent component including (i) a first portion disposed at a proximal end of the second stent component that is positionable radially inward of at least a portion of the native leaflet adjacent the first portion of the first stent component when the stent is implanted relative to the native valve, and (ii) a second portion disposed at a distal end of the second stent component, opposite the proximal end, wherein the distal end of the second stent component is positioned farther away from the native heart than the proximal end of the second stent component when the second stent component is implanted relative to the native heart valve; and a prosthetic valve component attached to the second stent component at the proximal end of the second stent component;wherein the first portion of the first stent component and the first portion of the second stent component are configured to clamp at least a portion of the native leaflet.
Priority Claims (1)
Number Date Country Kind
10 2005 051 849 Oct 2005 DE national
Parent Case Info

This is a continuation of U.S. patent application Ser. No. 11/589,570, filed Oct. 30, 2006, which is incorporated herein by reference.

US Referenced Citations (298)
Number Name Date Kind
4922905 Strecker May 1990 A
5002566 Carpentier et al. Mar 1991 A
5061277 Carpentier et al. Oct 1991 A
5094661 Levy et al. Mar 1992 A
5104407 Lam et al. Apr 1992 A
5197979 Quintero et al. Mar 1993 A
5279612 Eberhardt Jan 1994 A
5332402 Teitelbaum Jul 1994 A
5336258 Quintero et al. Aug 1994 A
5352240 Ross Oct 1994 A
5368608 Levy et al. Nov 1994 A
5411552 Andersen et al. May 1995 A
5456713 Chuter Oct 1995 A
5509930 Love Apr 1996 A
5549666 Hata et al. Aug 1996 A
5595571 Jaffe et al. Jan 1997 A
5613982 Goldstein Mar 1997 A
5632778 Goldstein May 1997 A
5674298 Levy et al. Oct 1997 A
5679112 Levy et al. Oct 1997 A
5683451 Lenker et al. Nov 1997 A
5697972 Kim et al. Dec 1997 A
5713953 Vallana et al. Feb 1998 A
5746775 Levy et al. May 1998 A
5755777 Chuter May 1998 A
5824041 Lenker et al. Oct 1998 A
5824080 Lamuraglia Oct 1998 A
5840081 Andersen et al. Nov 1998 A
5841382 Walden et al. Nov 1998 A
5843181 Jaffe et al. Dec 1998 A
5876434 Flomenblit et al. Mar 1999 A
5880242 Hu et al. Mar 1999 A
5899936 Goldstein May 1999 A
5928281 Huynh et al. Jul 1999 A
5935163 Gabbay Aug 1999 A
B151044 Lam et al. Sep 1999 I5
5957949 Leonhardt et al. Sep 1999 A
6001126 Nguyen-Thien-Nhon Dec 1999 A
5061277 Carpentier et al. Feb 2000 B1
6077297 Robinson et al. Jun 2000 A
6093530 McIlroy et al. Jul 2000 A
6102944 Huynh et al. Aug 2000 A
6117169 Moe Sep 2000 A
6126685 Lenker et al. Oct 2000 A
6168614 Andersen et al. Jan 2001 B1
6177514 Pathak et al. Jan 2001 B1
6183481 Lee et al. Feb 2001 B1
6200336 Pavcnik et al. Mar 2001 B1
6214055 Simionescu et al. Apr 2001 B1
6231602 Carpentier et al. May 2001 B1
6254564 Wilk et al. Jul 2001 B1
6254636 Peredo Jul 2001 B1
6283995 Moe et al. Sep 2001 B1
6287338 Sarnowski et al. Sep 2001 B1
6338740 Carpentier Jan 2002 B1
6342070 Nguyen-Thien-Nhon Jan 2002 B1
6344044 Fulkerson et al. Feb 2002 B1
6350278 Lenker et al. Feb 2002 B1
6379740 Rinaldi et al. Apr 2002 B1
6391538 Vyavahare et al. May 2002 B1
6425916 Garrison et al. Jul 2002 B1
6454799 Schreck Sep 2002 B1
6471723 Ashworth et al. Oct 2002 B1
6478819 Moe Nov 2002 B2
6508833 Pavcnik et al. Jan 2003 B2
6509145 Torrianni Jan 2003 B1
6521179 Girardot et al. Feb 2003 B1
6540782 Snyders Apr 2003 B1
6558417 Peredo May 2003 B2
6558418 Carpentier et al. May 2003 B2
6572642 Rinaldi et al. Jun 2003 B2
6582462 Andersen et al. Jun 2003 B1
6585766 Huynh et al. Jul 2003 B1
6613086 Moe et al. Sep 2003 B1
6682559 Myers et al. Jan 2004 B2
6730118 Spenser et al. May 2004 B2
6736845 Marquez et al. May 2004 B2
6767362 Schreck Jul 2004 B2
6790230 Beyersdorf et al. Sep 2004 B2
6808529 Fulkerson Oct 2004 B2
6821211 Otten et al. Nov 2004 B2
6821297 Snyders Nov 2004 B2
6824970 Vyavahare et al. Nov 2004 B2
6830584 Seguin Dec 2004 B1
6861211 Levy et al. Mar 2005 B2
6872226 Cali et al. Mar 2005 B2
6881199 Wilk et al. Apr 2005 B2
6893460 Spenser et al. May 2005 B2
6908481 Cribier Jun 2005 B2
6911043 Myers et al. Jun 2005 B2
6945997 Huynh et al. Sep 2005 B2
6974474 Pavcnik et al. Dec 2005 B2
7014655 Barbarash et al. Mar 2006 B2
7018406 Seguin et al. Mar 2006 B2
7037333 Myers et al. May 2006 B2
7050276 Nishiyama May 2006 B2
7078163 Torrianni Jul 2006 B2
7081132 Cook et al. Jul 2006 B2
7137184 Schreck Nov 2006 B2
7141064 Scott et al. Nov 2006 B2
7163556 Xie et al. Jan 2007 B2
7189259 Simionescu et al. Mar 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7238200 Lee et al. Jul 2007 B2
7252682 Seguin Aug 2007 B2
7318278 Zhang et al. Jan 2008 B2
7318998 Goldstein et al. Jan 2008 B2
7322932 Xie et al. Jan 2008 B2
7329278 Seguin et al. Feb 2008 B2
7381218 Schreck Jun 2008 B2
7393360 Spenser et al. Jul 2008 B2
7399315 Iobbi Jul 2008 B2
7452371 Pavcnik et al. Nov 2008 B2
7473275 Marquez Jan 2009 B2
7896915 Guyenot et al. Mar 2011 B2
7914575 Guyenot et al. Mar 2011 B2
8398704 Straubinger et al. Mar 2013 B2
8465540 Straubinger et al. Jun 2013 B2
8468667 Straubinger et al. Jun 2013 B2
8551160 Figulla et al. Oct 2013 B2
20010011187 Pavcnik et al. Aug 2001 A1
20010039450 Pavcnik et al. Nov 2001 A1
20020032481 Gabbay Mar 2002 A1
20020055775 Carpentier et al. May 2002 A1
20020123790 White et al. Sep 2002 A1
20020133226 Marquez et al. Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020193871 Beyersdorf et al. Dec 2002 A1
20020198594 Schreck Dec 2002 A1
20030014104 Cribier Jan 2003 A1
20030023300 Bailey et al. Jan 2003 A1
20030027332 Lafrance et al. Feb 2003 A1
20030036791 Philipp et al. Feb 2003 A1
20030036795 Andersen et al. Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030050694 Yang et al. Mar 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030065386 Weadock Apr 2003 A1
20030109924 Cribier Jun 2003 A1
20030114913 Spenser et al. Jun 2003 A1
20030125795 Pavcnik et al. Jul 2003 A1
20030139796 Sequin et al. Jul 2003 A1
20030139803 Sequin et al. Jul 2003 A1
20030149476 Damm et al. Aug 2003 A1
20030149478 Figulla et al. Aug 2003 A1
20030153974 Spenser et al. Aug 2003 A1
20030195620 Huynh et al. Oct 2003 A1
20030236570 Cook et al. Dec 2003 A1
20040006380 Buck et al. Jan 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040049262 Obermiller et al. Mar 2004 A1
20040073289 Hartley et al. Apr 2004 A1
20040078950 Schreck et al. Apr 2004 A1
20040102855 Shank May 2004 A1
20040117004 Osborne et al. Jun 2004 A1
20040117009 Cali et al. Jun 2004 A1
20040148018 Carpentier et al. Jul 2004 A1
20040153145 Simionescu et al. Aug 2004 A1
20040186558 Pavcnik et al. Sep 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040193244 Hartley et al. Sep 2004 A1
20040210301 Obermiller et al. Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040260389 Case et al. Dec 2004 A1
20050009000 Wilhelm et al. Jan 2005 A1
20050033220 Wilk et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050049692 Numamoto et al. Mar 2005 A1
20050075725 Rowe Apr 2005 A1
20050075776 Cho Apr 2005 A1
20050096726 Sequin et al. May 2005 A1
20050096735 Hojeibane et al. May 2005 A1
20050096736 Osse et al. May 2005 A1
20050098547 Cali et al. May 2005 A1
20050113910 Paniagua et al. May 2005 A1
20050119728 Sarac Jun 2005 A1
20050119736 Zilla et al. Jun 2005 A1
20050137687 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137697 Salahieh et al. Jun 2005 A1
20050137698 Salahieh et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050143804 Haverkost Jun 2005 A1
20050143807 Pavcnik et al. Jun 2005 A1
20050149166 Schaeffer et al. Jul 2005 A1
20050150775 Zhang et al. Jul 2005 A1
20050171597 Boatman et al. Aug 2005 A1
20050171598 Schaeffer Aug 2005 A1
20050192665 Spenser et al. Sep 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050222668 Schaeffer et al. Oct 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050267560 Bates Dec 2005 A1
20060009842 Huynh et al. Jan 2006 A1
20060025857 Bergheim et al. Feb 2006 A1
20060047343 Oviatt et al. Mar 2006 A1
20060058864 Schaeffer et al. Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060074485 Realyvasquez Apr 2006 A1
20060111770 Pavcnik et al. May 2006 A1
20060142846 Pavcnik et al. Jun 2006 A1
20060149360 Schwammenthal et al. Jul 2006 A1
20060155366 LaDuca et al. Jul 2006 A1
20060167543 Bailey et al. Jul 2006 A1
20060178740 Stacchino et al. Aug 2006 A1
20060193885 Neethling et al. Aug 2006 A1
20060210597 Hiles Sep 2006 A1
20060224183 Freudenthal Oct 2006 A1
20060229718 Marquez Oct 2006 A1
20060229719 Marquez et al. Oct 2006 A1
20060246584 Covelli Nov 2006 A1
20060259134 Schwammenthal et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060271161 Meyer et al. Nov 2006 A1
20060287717 Rowe et al. Dec 2006 A1
20060287719 Rowe et al. Dec 2006 A1
20060290027 O'Connor et al. Dec 2006 A1
20060293745 Carpentier et al. Dec 2006 A1
20070005129 Damm et al. Jan 2007 A1
20070005131 Taylor Jan 2007 A1
20070005132 Simionescu et al. Jan 2007 A1
20070020248 Everaerts et al. Jan 2007 A1
20070021826 Case et al. Jan 2007 A1
20070027535 Purdy, Jr. et al. Feb 2007 A1
20070032856 Limon Feb 2007 A1
20070038291 Case et al. Feb 2007 A1
20070038295 Case et al. Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070050014 Johnson Mar 2007 A1
20070088431 Bourang et al. Apr 2007 A1
20070093887 Case et al. Apr 2007 A1
20070100435 Case et al. May 2007 A1
20070100440 Figulla et al. May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070123700 Ueda et al. May 2007 A1
20070123979 Perier et al. May 2007 A1
20070142906 Figulla et al. Jun 2007 A1
20070162103 Case et al. Jul 2007 A1
20070173932 Cali et al. Jul 2007 A1
20070179592 Schaeffer Aug 2007 A1
20070185565 Schwammenthal et al. Aug 2007 A1
20070203576 Lee et al. Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070239271 Nguyen Oct 2007 A1
20070244551 Stobie Oct 2007 A1
20070260327 Case et al. Nov 2007 A1
20070288087 Fearnot et al. Dec 2007 A1
20080004688 Spenser et al. Jan 2008 A1
20080021546 Patz et al. Jan 2008 A1
20080033534 Cook et al. Feb 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080071363 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071368 Tuval et al. Mar 2008 A1
20080071369 Tuval et al. Mar 2008 A1
20080077236 Letac et al. Mar 2008 A1
20080086205 Gordy et al. Apr 2008 A1
20080097586 Pavcnik et al. Apr 2008 A1
20080102439 Tian et al. May 2008 A1
20080133003 Seguin et al. Jun 2008 A1
20080140189 Nguyen et al. Jun 2008 A1
20080154355 Benichou et al. Jun 2008 A1
20080200977 Paul et al. Aug 2008 A1
20080215143 Seguin Sep 2008 A1
20080255660 Guyenot et al. Oct 2008 A1
20080255661 Straubinger et al. Oct 2008 A1
20080262602 Wilk et al. Oct 2008 A1
20080269878 Iobbi Oct 2008 A1
20080275549 Rowe Nov 2008 A1
20090216310 Straubinger et al. Aug 2009 A1
20090216313 Straubinger et al. Aug 2009 A1
20090222076 Figulla et al. Sep 2009 A1
20090234443 Ottma et al. Sep 2009 A1
20100174362 Straubinger et al. Jul 2010 A1
20100249915 Zhang Sep 2010 A1
20100249916 Zhang Sep 2010 A1
20100249917 Zhang Sep 2010 A1
20100249918 Zhang Sep 2010 A1
20100292779 Straubinger et al. Nov 2010 A1
20110015616 Straubinger et al. Jan 2011 A1
20110106244 Ferrari et al. May 2011 A1
20110238159 Guyenot et al. Sep 2011 A1
20110288626 Straubinger et al. Nov 2011 A1
20110295363 Girard et al. Dec 2011 A1
20130079869 Straubinger et al. Mar 2013 A1
20130144203 Wilk et al. Jun 2013 A1
20130178930 Straubinger et al. Jul 2013 A1
20130253635 Straubinger et al. Sep 2013 A1
Foreign Referenced Citations (207)
Number Date Country
2006308187 May 2007 AU
2006310681 May 2007 AU
2436258 Jan 2005 CA
2436258 Jan 2005 CA
2595233 Jul 2006 CA
2595233 Jul 2006 CA
2627555 May 2007 CA
19 546 692 Jun 1997 DE
195 46 692 Jun 1997 DE
20 00 3874 Jun 2000 DE
19 857 887 Jul 2000 DE
19857887 Jul 2000 DE
10 010 073 Sep 2001 DE
10 010 074 Oct 2001 DE
10010074 Oct 2001 DE
10 121 210 Nov 2002 DE
19 546 692 Nov 2002 DE
101 21 210 Nov 2002 DE
19546692 Nov 2002 DE
10 301 026 Feb 2004 DE
10335948 Jul 2004 DE
10 302 447 Feb 2005 DE
10 010 074 Apr 2005 DE
19857887 May 2005 DE
10 010 073 Dec 2005 DE
10 2005 051 849 May 2007 DE
10 2005 05262 May 2007 DE
20 2007 005 491 Jul 2007 DE
0 084 395 Jul 1983 EP
0 402 036 Dec 1990 EP
0 402 176 Dec 1990 EP
0402036 Dec 1990 EP
0402176 Dec 1990 EP
0 458 877 Apr 1991 EP
0 515 324 Nov 1992 EP
0 547 135 Jun 1993 EP
0871414 Sep 1995 EP
0756498 Oct 1995 EP
0 592 410 Nov 1995 EP
0786970 May 1996 EP
0 729 364 Sep 1996 EP
0 756 498 May 1997 EP
0 778 775 Jun 1997 EP
0786970 Aug 1997 EP
0888142 Sep 1997 EP
0971649 Oct 1998 EP
0 928 615 Jul 1999 EP
1051204 Jul 1999 EP
0458877 Aug 1999 EP
0 592 410 Oct 1999 EP
1089676 Dec 1999 EP
0 986 348 Mar 2000 EP
1117446 Apr 2000 EP
1 164 976 Aug 2000 EP
1158937 Sep 2000 EP
1 041 942 Oct 2000 EP
1 041 943 Oct 2000 EP
1041942 Oct 2000 EP
1041943 Oct 2000 EP
1171061 Oct 2000 EP
1206179 Feb 2001 EP
1 117 446 Jul 2001 EP
1 255 510 Aug 2001 EP
1259193 Sep 2001 EP
1 206 179 May 2002 EP
1347785 Aug 2002 EP
1235537 Sep 2002 EP
1 251 804 Oct 2002 EP
1248655 Oct 2002 EP
1251804 Oct 2002 EP
1257305 Nov 2002 EP
0 971 649 Dec 2002 EP
1395208 Dec 2002 EP
1 401 359 Jan 2003 EP
1406561 Jan 2003 EP
1 281 375 Feb 2003 EP
1281357 Feb 2003 EP
1408882 Feb 2003 EP
1 435 878 Apr 2003 EP
1 435 879 Apr 2003 EP
1 441 672 Jun 2003 EP
1 017 868 Sep 2003 EP
1354569 Oct 2003 EP
1494616 Oct 2003 EP
1 519 697 Jan 2004 EP
1 539 047 Apr 2004 EP
1551274 Apr 2004 EP
1 560 542 May 2004 EP
1414295 May 2004 EP
1 452 153 Sep 2004 EP
1 603 493 Sep 2004 EP
0 987 998 Oct 2004 EP
1 087 727 Nov 2004 EP
1 233 731 Dec 2004 EP
1 499 366 Jan 2005 EP
1 663 070 Mar 2005 EP
1 253 875 Apr 2005 EP
1 667 614 Apr 2005 EP
1 251 803 Jun 2005 EP
1 702 247 Jul 2005 EP
1734902 Aug 2005 EP
1 469 797 Nov 2005 EP
1835948 Jun 2006 EP
1 690 515 Aug 2006 EP
1863545 Sep 2006 EP
1893132 Nov 2006 EP
1901681 Dec 2006 EP
1 251 805 Mar 2007 EP
1 255 510 Mar 2007 EP
1835948 Sep 2007 EP
1 112 042 Nov 2007 EP
1 878 407 Jan 2008 EP
1 886 649 Feb 2008 EP
1 900 343 Mar 2008 EP
1 259 195 Oct 2008 EP
1 980 220 Oct 2008 EP
1259195 Oct 2008 EP
1 99 4913 Nov 2008 EP
2 000 115 Dec 2008 EP
2 828 263 Feb 2003 FR
2433700 Jul 2007 GB
2440809 Feb 2008 GB
2003-523262 Aug 2003 JP
2003-524504 Aug 2003 JP
2005-118585 May 2005 JP
2007-296375 Nov 2007 JP
WO 9009102 Aug 1990 WO
WO 9511055 Apr 1995 WO
WO 9524873 Sep 1995 WO
WO 9528183 Oct 1995 WO
WO 9613227 May 1996 WO
WO 9732615 Sep 1997 WO
WO 9843556 Oct 1998 WO
WO-9843556 Oct 1998 WO
WO 9846165 Oct 1998 WO
WO 9937337 Jul 1999 WO
WO 9966863 Dec 1999 WO
WO 0015148 Mar 2000 WO
WO 0018445 Apr 2000 WO
WO 0025702 May 2000 WO
WO 0047139 Aug 2000 WO
WO 0053125 Sep 2000 WO
WO 0062714 Oct 2000 WO
WO 0110209 Feb 2001 WO
WO 0135870 May 2001 WO
WO 0141679 Jun 2001 WO
WO 0151104 Jul 2001 WO
WO 0154625 Aug 2001 WO
WO 0158503 Aug 2001 WO
WO 0162189 Aug 2001 WO
WO 0164137 Sep 2001 WO
WO 0236048 May 2002 WO
WO 02058745 Aug 2002 WO
WO 02100301 Dec 2002 WO
WO 02102286 Dec 2002 WO
WO 03003949 Jan 2003 WO
WO 03007795 Jan 2003 WO
WO 03009785 Feb 2003 WO
WO 03011195 Feb 2003 WO
WO 03013239 Feb 2003 WO
WO 03028592 Apr 2003 WO
WO 03047468 Jun 2003 WO
WO 03079928 Oct 2003 WO
WO 03096935 Nov 2003 WO
WO 2004004597 Jan 2004 WO
WO 2004016200 Feb 2004 WO
WO 2004016201 Feb 2004 WO
WO 2004019825 Mar 2004 WO
WO 2004026117 Apr 2004 WO
WO 2004026173 Apr 2004 WO
WO 2004028399 Apr 2004 WO
WO 2004043301 May 2004 WO
WO 2004082527 Sep 2004 WO
WO 2004082528 Sep 2004 WO
WO 2004096100 Nov 2004 WO
WO 2005021063 Mar 2005 WO
WO 2005034812 Apr 2005 WO
WO 2005062980 Jul 2005 WO
WO 2005062980 Jul 2005 WO
WO 2005063980 Jul 2005 WO
WO 2005070343 Aug 2005 WO
WO 2005072654 Aug 2005 WO
WO 2006066327 Jun 2006 WO
WO 2006076890 Jul 2006 WO
WO 2006102063 Sep 2006 WO
WO 2006108090 Oct 2006 WO
WO 2006124649 Nov 2006 WO
WO 2006127756 Nov 2006 WO
WO 2006127765 Nov 2006 WO
WO 2006132948 Dec 2006 WO
WO 2007047488 Apr 2007 WO
WO 2007047945 Apr 2007 WO
WO 2007051620 May 2007 WO
WO 2007059252 May 2007 WO
WO 2007071436 Jun 2007 WO
WO 2007098232 Aug 2007 WO
WO 2007120543 Oct 2007 WO
WO 2008028569 Mar 2008 WO
WO 2008035337 Mar 2008 WO
WO 2008045949 Apr 2008 WO
WO 2008070797 Jun 2008 WO
WO 2006076890 Jul 2008 WO
WO 2008079962 Jul 2008 WO
WO 2008101083 Aug 2008 WO
WO 2008125153 Oct 2008 WO
WO 2008138584 Nov 2008 WO
WO 2008150529 Dec 2008 WO
Non-Patent Literature Citations (13)
Entry
Aortenklappenbioprothese erfolgreich in der Entwicklung, May 16, 2003 (1 page).
English translation of Aortenklappenbioprotheseerfolgreich in der Entwicklung (2 pages).
Screen shots from http://www.fraunhofer.de/presse/filme/2006/index.jsp, 2006 (2 pages).
Liang, Ma, et al., “Double-crowned valved stents for off-pump mitral valve replacement,” Eur. J. Cardio-Thoracic Surgery, vol. 28, pp. 194-198 (2005) (5 pages).
Huber, Christoph H., et al. “Direct Access Valve Replacement (DAVR)—are we entering a new era in cardiac surgery?” Eur. J. Cardio-Thoracic Surgery, vol. 29, pp. 380-385 (2006) (6 pages).
English translation of DE 19 546 692 A1 (4 pages).
English translation of EP 1 469 797 B1 (16 pages).
Klein, Allan L. et al., “Age-related Prevalence of Valvular Regurgitation in Normal Subjects: A Comprehensive Color Flow Examination of 118 Volunteers,” J. Am. Soc. Echocardiography, vol. 3, No. 1, pp. 54-63 (1990) (10 pages).
Gummert, J.F. et al., “Cardiac Surgery in Germany During 2007: A Report on Behalf of the German Society for Thoracic and Cardiovascular Surgery,” Thorac. Cardiov. Surg., vol. 56, pp. 328-336 (2008) (9 pages).
Gummert, J.F. et al., “Cardiac Surgery in Germany During 2006: A Report on Behalf of the German Society for Thoracic and Cardiovascular Surgery,” Thorac. Cardiov. Surg., vol. 55, pp. 343-350 (2007) (8 pages).
File history for German Patent DE 195 46 692 filed Dec. 14, 1995 and patented Jul. 11, 2002.
International Search Report for PCT/EP2006/010023.
Translation of Aortenklappenbioprothese erfolgreich in der Entwicklung (2 pages).
Continuations (1)
Number Date Country
Parent 11589570 Oct 2006 US
Child 13315913 US
Reissues (1)
Number Date Country
Parent 13315913 Dec 2011 US
Child 14454334 US